GlassScriptPhysician profile
Stanley A Anderson
NPI 1972636306
$4,655.95
in general payments reported to CMS, 2019-2025
18 companies · $1,176 in 2025
The $1,176 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,054 · 2022: $764 · 2023: $570 · 2024: $1,092 · 2025: $1,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,552 · Education: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,552.24 |
| Education | $286.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $857.25 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $810.55 | 2021-2025 | Ilumya, Winlevi |
| Janssen Biotech, INC. | $700.95 | 2021-2025 | Tremfya |
| Lilly USA, LLC | $607.70 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $413.88 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $411.53 | 2021-2025 | |
| Amgen INC. | $153.53 | 2021-2025 | Otezla, Otezla |
| Ucb, INC. | $151.07 | 2021-2025 | Bimzelx |
| Pfizer INC. | $148.53 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $114.70 | 2021-2023 | Libtayo |
| Leo Pharma INC. | $60.94 | 2023-2025 | Adbry, Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $55.45 | 2022-2025 | Sotyktu |
| Medtronic, INC. | $39.53 | 2022-2023 | Venaseal |
| Incyte Corporation | $35.52 | 2022 | |
| Arcutis Biotherapeutics, INC. | $33.20 | 2025 | Zoryve |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $23.62 | 2025 | |
| Biofrontera INC. | $21.29 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Dermavant Sciences, INC. | $16.71 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.